Announcements
- Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform
- Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Alector to Participate in Upcoming Healthcare Conferences
- Alector Reports First Quarter 2024 Financial Results and Provides Business Update
- Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
- Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
- FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
- Alector Announces Closing of Public Offering
- Alector Announces Pricing of Public Offering of Common Stock
More ▼
Key statistics
As of last trade, Alector Inc (0Z2:MUN) traded at 4.20, 18.64% above the 52 week low of 3.54 set on Nov 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.20 |
---|---|
High | 4.20 |
Low | 4.20 |
Bid | 4.04 |
Offer | 4.06 |
Previous close | 4.20 |
Average volume | 0.00 |
---|---|
Shares outstanding | 96.38m |
Free float | 87.94m |
P/E (TTM) | -- |
Market cap | 421.20m USD |
EPS (TTM) | -1.39 USD |
Data delayed at least 15 minutes, as of Jun 10 2024 07:16 BST.
More ▼